DPP-1 inhibitor
DPP1 Inhibitors: First FDA Approval — China’s Fast-Follow Pipeline
Brensocatib earns FDA approval for NCFB, marking the first validated DPP1 inhibitor. We review the global and China pipelines, including HSK31858 and XH-S004.
DPP-1 inhibitor
Brensocatib earns FDA approval for NCFB, marking the first validated DPP1 inhibitor. We review the global and China pipelines, including HSK31858 and XH-S004.
DPP-1 inhibitor
On August 11, Fosun Pharma took another step in its strategy to globalize its innovation pipeline, out-licensing its oral small-molecule DPP-1 inhibitor XH-S004 to San Francisco-based Expedition Therapeutics for territories outside mainland China, Hong Kong, and Macau. The deal could be worth up to $645 million in upfront, milestone, and